Pregeb 150 mg (Pregabalin) Medically reviewed by Sanjay Gangani, B.Pharm, CMO & Pharmacist
Active Ingredient Pregabalin Indication Neuropathic pain, Epilepsy/Seizures and Fibromyalgia Manufacturer Torrent Pharmaceuticals Ltd Strength:- 150mg Packaging 10 Capsules in srip
INQUIRE ABOUT Pregeb 150 mg (Pregabalin)
WHAT IS PREGEB 150 Pregeb 150 is a pregabalin capsule from Torrent Pharmaceuticals.
Each capsule contains Pregeb 75 mg of pregabalin.
Pregabalin is a prescription medicine for nerve pain and seizures.
It belongs to a group called gabapentinoids.
It is not an ordinary painkiller and not an anti-inflammatory.
It treats pain caused by damaged or irritated nerves.
That includes diabetic nerve pain in the feet and legs.
It also includes nerve pain after shingles.
It also includes nerve pain after a spinal cord injury.
It is used as add-on treatment for certain seizures.
It is used for fibromyalgia in some countries.
It is also used for generalised anxiety disorder in Europe.
It works within days to weeks, not within minutes.
It can cause physical dependence and is misused by some people.
HOW IT WORKS (MECHANISM OF ACTION) Step by step Damaged nerves become overexcitable and fire too easily.
Nerve endings release signalling chemicals when calcium enters them.
Pregabalin binds the alpha-2-delta subunit of calcium channels.
That subunit is an auxiliary part of voltage-gated calcium channels.
Binding reduces how much calcium enters the nerve ending.
Less calcium means less release of excitatory chemicals.
Those chemicals include glutamate, noradrenaline and substance P.
Nerve signalling therefore quietens down.
Pain signals reaching the brain are reduced.
In epilepsy, the same effect reduces seizure spread.
What it is not It is not an opioid and does not act on opioid receptors.
It is not a benzodiazepine , although it can sedate like one.
It does not bind GABA receptors despite the similar name.
It does not reduce inflammation.
It will not help ordinary muscle or joint pain.
Pregabalin is cleared almost entirely by the kidneys, unchanged.
So the dose must be cut when kidney function is reduced.
It is barely metabolised, so liver enzyme interactions are few.
That is why its main interactions are additive, not metabolic.
DOSAGE GUIDE Every dose is set by a doctor. Pregabalin is titrated upward slowly and must never be stopped suddenly.
Dosing by indication, in adults Indication Starting dose Titration Maximum Diabetic peripheral neuropathy pain 50 mg three times daily (150 mg/day) To 300 mg/day within 1 week 300 mg/day; higher not recommended Pain after shingles (postherpetic neuralgia) 75 mg twice daily or 50 mg three times daily (150 mg/day) To 300 mg/day within 1 week 600 mg/day Nerve pain after spinal cord injury 75 mg twice daily (150 mg/day) To 300 mg/day within 1 week 600 mg/day Fibromyalgia 75 mg twice daily (150 mg/day) To 300 mg/day within 1 week 450 mg/day; higher not recommended Add-on for partial-onset seizures, adults 150 mg/day in 2 or 3 doses By response and tolerability 600 mg/day
Notice that 150 mg per day is the starting dose in every row.
A single 150 mg capsule is therefore a whole starting day’s dose.
One 150 mg capsule twice daily equals 300 mg per day.
That is the usual target dose, reached after about a week.
Diabetic nerve pain should not exceed 300 mg per day.
Fibromyalgia should not exceed 450 mg per day.
Kidney function changes the dose completely Pregabalin leaves the body through the kidneys. The dose must be matched to creatinine clearance. This table is from the FDA label.
Creatinine clearance Total daily dose range How to divide it 60 mL/min or more 150, 300, 450 or 600 mg/day Two or three doses 30 to 60 mL/min 75, 150, 225 or 300 mg/day Two or three doses 15 to 30 mL/min 25 to 50, 75, 100 to 150, or 150 mg/day Once or twice daily Less than 15 mL/min 25, 25 to 50, 50 to 75, or 75 mg/day Once daily
A 150 mg capsule is unsuitable for anyone with a creatinine clearance below 30 mL/min. Those patients need 25 mg or 75 mg strengths.
At 30 to 60 mL/min the daily maximum is 300 mg.
So one 150 mg capsule twice daily is already the ceiling there.
Diabetic nerve pain dosing assumes clearance of at least 60 mL/min.
Haemodialysis patients need an extra dose after each session.
That supplemental dose is set by the label, not by the patient.
Never stop pregabalin suddenly.
Taper the dose over a minimum of one week.
Abrupt stopping can trigger seizures, even without epilepsy.
Withdrawal symptoms include insomnia, nausea and headache.
They also include anxiety, sweating and diarrhoea.
Your doctor should plan the taper.
Take it as soon as you remember, if it is not nearly time.
Skip it if the next dose is nearly due.
Never take two doses together.
Tell your doctor if you miss doses often.
HOW TO TAKE IT Taking the capsule Take it only on a doctor’s prescription.
Swallow the capsule whole with water.
Do not open, chew or crush the capsule.
It can be taken with or without food.
Take it at the same times every day.
Space two daily doses about 12 hours apart.
Space three daily doses about 8 hours apart.
Keep taking it even once the pain improves.
Expect several days to a few weeks for full benefit.
Living with the first two weeks Dizziness and drowsiness are common at the start.
They usually settle as the body adjusts.
Do not drive until you know how it affects you.
Do not operate machinery or work at height.
Get up slowly from sitting or lying.
Falls and fractures have been reported from the dizziness.
Tell your doctor if the dizziness does not settle.
Never drink alcohol while taking it.
Never combine it with opioid painkillers without medical advice.
Never combine it with sleeping tablets without medical advice.
Never raise your own dose to get more effect.
Never stop it suddenly.
Never share your capsules with anyone else.
Never buy it without a prescription.
PRECAUTIONS Absolute contraindications Known hypersensitivity to pregabalin or any excipient.
Any previous angioedema caused by pregabalin.
Any previous severe skin reaction to pregabalin.
Stop it immediately at the first sign of angioedema.
Stop it immediately for blistering, hives or wheezing.
Conditions to disclose to your doctor Any kidney disease, or dialysis.
Heart failure, especially NYHA class III or IV.
Any previous episode of facial or throat swelling.
Treatment with an ACE inhibitor, which also causes angioedema.
Any lung disease such as COPD or severe asthma.
Sleep apnoea or any breathing problem during sleep.
Current treatment with opioid painkillers.
Current treatment with benzodiazepines or sleeping tablets.
Any history of depression or suicidal thoughts.
Any history of drug or alcohol misuse.
Diabetes, especially if on a glitazone tablet.
Any eye disease or visual problem.
Any bleeding or platelet disorder.
Pregnancy, planned pregnancy or breastfeeding.
Older age, which raises the breathing and falls risk.
Food, drink and lifestyle precautions There are no food restrictions; take it with or without food.
Avoid alcohol completely while taking pregabalin.
Alcohol adds to the drowsiness and breathing risk.
Do not use recreational sedatives with it.
Weigh yourself regularly; weight gain is common.
Watch for swelling of the ankles and feet.
Keep up gentle activity to limit weight gain.
Tell your dentist and every doctor that you take it.
Do not drive until you are sure it does not affect you.
Before-use safety checklist Do you have a valid prescription from a registered practitioner?
Has the cause of your pain been diagnosed?
Has your kidney function been measured?
Is 150 mg the right strength for your kidney function?
Should you be starting on 75 mg or 50 mg instead?
Are you taking any opioid or sedative medicine?
Do you have any lung or breathing condition?
Are you taking an ACE inhibitor?
Do you know not to drink alcohol with it?
Do you know not to drive until you know its effect?
Do you know never to stop it suddenly?
Do you know which symptoms need emergency care?
SIDE EFFECTS Common side effects, with figures Side effect On pregabalin On placebo Dizziness 30% 8% Drowsiness (somnolence) 23% 8% Blurred vision 7% 2% Swelling of hands or feet (peripheral oedema) 6% 2% Weight gain of 7% or more 9% 2% Dry mouth Among the most common Lower Abnormal thinking or difficulty concentrating Among the most common Lower
Figures by condition treated Condition and dose Dizziness Drowsiness Other Diabetic nerve pain, 300 mg/day 23% vs 5% 13% vs 3% Peripheral oedema 9% vs 2%; weight gain 4% vs 0% Pain after shingles, 300 mg/day 31% vs 9% 18% vs 5% Peripheral oedema 16% vs 4% Fibromyalgia, all doses 38% vs 9% 20% vs 4% Weight increased 11% vs 2% Spinal cord injury pain 20.9% vs 6.9% 35.7% vs 11.5% Peripheral oedema 10.4% vs 5.2%
Average weight gain in diabetic patients was 1.6 kg.
On placebo the average gain was 0.3 kg.
In a two-year group of 333 patients the average gain was 5.2 kg.
Between 9% and 19% of patients stopped because of side effects.
Less common but serious effects Effect Figures or detail Action Angioedema Life-threatening respiratory compromise reported Emergency; stop the drug Severe skin or allergic reaction Blisters, hives, rash, wheezing Emergency; stop the drug Respiratory depression Serious, life-threatening or fatal with opioids or lung disease Emergency Suicidal thoughts or behaviour Antiepileptics roughly doubled the risk; 0.43% versus 0.24% Tell a doctor the same day Raised creatine kinase At least 3 times normal in 1.5% versus 0.7% Report unexplained muscle pain Rhabdomyolysis (muscle breakdown) Three cases in premarketing trials Emergency Low platelet count Clinically significant fall in 3% versus 2% Report easy bruising or bleeding PR interval prolongation on ECG Mean increase of 3 to 6 msec at 300 mg/day or more Doctor interprets Breast enlargement in men (gynaecomastia) Reported after marketing Tell the doctor Bullous pemphigoid Reported after marketing Urgent review
Dependence and misuse Pregabalin is a Schedule V controlled substance in the United States.
It became a Schedule H1 drug in India in May 2026.
A single 450 mg dose was rated like 30 mg of diazepam.
That rating came from recreational sedative users.
Euphoria was reported by 4% of patients versus 1% on placebo.
In some groups euphoria reached 12%.
Stopping suddenly causes withdrawal, showing physical dependence.
Reported withdrawal effects include seizures and depression.
DRUG INTERACTIONS – AVOID WITH The most dangerous combinations Medicine group Effect Instruction Opioid painkillers such as tramadol, morphine, codeine Serious, life-threatening or fatal respiratory depression Avoid unless a doctor has judged it necessary Benzodiazepines such as alprazolam, clonazepam, diazepam Added sedation and breathing depression Avoid Sleeping tablets such as zolpidem or eszopiclone Added sedation and breathing depression Avoid Sedating antihistamines Added sedation Avoid Alcohol Added sedation and impaired coordination Avoid completely
Other interactions that matter Medicine Effect Thiazolidinediones such as pioglitazone Peripheral oedema in 19% on both, versus 8% on pregabalin alone ACE inhibitors such as ramipril or enalapril Both can cause angioedema; risk may be additive Opioid painkillers, bowel effects Reports of constipation, paralytic ileus and intestinal obstruction Other antiepileptic drugs No clinically relevant interaction found Oral contraceptives No clinically relevant interaction found Gabapentin No pharmacokinetic interaction; combination not studied
On a thiazolidinedione alone, peripheral oedema was 3%.
On pregabalin alone it was 8%.
On both together it was 19%.
Pregabalin is barely metabolised, so liver enzyme interactions are few.
Its risks come from added sedation, not from changed blood levels.
What to tell your pharmacist List every painkiller, including any opioid.
List every sleeping tablet or anti-anxiety tablet.
List every diabetes tablet.
List every blood pressure tablet.
Mention any lung condition or sleep apnoea.
Mention how much alcohol you drink, honestly.
EMERGENCY WARNING SIGNS Get emergency medical help for any of these.
Signs of angioedema or a severe allergic reaction Swelling of the face, lips, gums, tongue or neck.
Swelling inside the mouth or throat.
Difficulty breathing or swallowing.
Wheezing or a tight chest.
Widespread hives or blistering of the skin.
Peeling skin or sores in the mouth.
Very slow or shallow breathing.
Long pauses in breathing, especially during sleep.
Being hard to wake, or unresponsive.
Blue or grey lips or fingertips.
Severe confusion with heavy drowsiness.
Mental health warning signs New or worsening thoughts of self-harm or suicide.
New or worsening depression.
Sudden agitation, irritability or aggression.
Sudden changes in mood or behaviour.
Panic attacks or severe restlessness.
These need medical attention the same day.
A seizure, especially after stopping the drug suddenly.
Unexplained muscle pain, tenderness or weakness.
Dark or cola-coloured urine with muscle pain.
Easy bruising or unexplained bleeding.
Rapid swelling of the legs with breathlessness.
Sudden loss or blurring of vision.
Contact a doctor or poisons service immediately.
Take the pack with you so the dose is known.
Do not wait for symptoms to appear.
WHY CHOOSE THIS MEDICINE Points in its favour Pregabalin is a first-line option for several nerve pain conditions.
It is approved for diabetic nerve pain and for post-shingles pain.
It is approved for nerve pain after spinal cord injury.
It is approved as add-on treatment for partial-onset seizures.
It is also approved for fibromyalgia in the United States.
Ordinary painkillers often do not help nerve pain at all.
It is taken two or three times a day, not more often.
It is barely metabolised, so enzyme interactions are few.
That makes it simpler than many other nerve pain drugs.
Torrent Pharmaceuticals is a large, established Indian manufacturer.
The brand is available in several strengths for titration.
Points to be honest about Dizziness affects about 30% of patients.
Drowsiness affects about 23%.
Nearly one in ten gains 7% or more of body weight.
Between 9% and 19% stop treatment because of side effects.
It can cause physical dependence and withdrawal.
It is misused, which is why India tightened its control.
It must never be stopped abruptly.
Do not describe it as a general painkiller.
Do not describe it as non-habit-forming.
Do not describe it as a sleep aid or a relaxant.
Do not describe it as safe to combine with opioids.
Do not promote it for anxiety without a prescription context.
STORAGE INSTRUCTIONS Store at room temperature, ideally 20 C to 25 C.
Keep the capsules in the original strip or container.
Protect them from moisture and from light.
Do not store them in a bathroom cabinet.
Do not transfer them into an unlabelled container.
Keep them out of the sight and reach of children.
Do not use after the expiry date on the strip.
Return unused or expired capsules to a pharmacy.
Do not keep leftover capsules for a future pain episode.
Do not pass unused capsules to anyone else.
Extra storage care for a Schedule H1 drug Keep retail stock in a secure, controlled location.
Reconcile stock against the H1 register regularly.
Investigate any discrepancy promptly.
Keep the register and prescription copies for three years.
Dispose of expired stock through a documented route.
Sanjay Gangani
B.Pharm, CMO & Pharmacist
Licensed pharmacist (B.Pharm) with 12+ years in clinical pharmacy and patient care. Reviews every article for evidence-based accuracy before it is published on ACTIZA Store.
Reviews
There are no reviews yet.